Find Orpidan manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2019-25-2, Orpidan, Chlorazanil hcl, Chlorazanil (hydrochloride), Doclizid-t, Nsc-60256
Molecular Formula
C9H9Cl2N5
Molecular Weight
258.10  g/mol
InChI Key
UYCMHUVQSSDLAM-UHFFFAOYSA-N
FDA UNII
9961SL881J

Orpidan
Chlorazanil Hydrochloride is the hydrochoride salt form of chlorazanil, a triazine derivative and diuretic agent. Chlorazanil appears to prevent the absorption of sodium and chloride in the distal convoluted tubule.
1 2D Structure

Orpidan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-N-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine;hydrochloride
2.1.2 InChI
InChI=1S/C9H8ClN5.ClH/c10-6-1-3-7(4-2-6)14-9-13-5-12-8(11)15-9;/h1-5H,(H3,11,12,13,14,15);1H
2.1.3 InChI Key
UYCMHUVQSSDLAM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1NC2=NC=NC(=N2)N)Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
9961SL881J
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2019-25-2

2. Orpidan

3. Chlorazanil Hcl

4. Chlorazanil (hydrochloride)

5. Doclizid-t

6. Nsc-60256

7. N-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine Monohydrochloride

8. 9961sl881j

9. 2-n-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine;hydrochloride

10. 2-amino-4-p-chloroanilino-s-triazine Hydrochloride

11. Unii-9961sl881j

12. Einecs 217-962-4

13. Chlorazanil Hydrochlorideide

14. Chembl2104101

15. Schembl22207597

16. Dtxsid00942254

17. S-triazine, 2-amino-4-(p-chloroanilino)-, Monohydrochloride

18. Hy-b1045

19. Nsc60256

20. 1,3,5-triazine-2,4-diamine, N-(4-chlorophenyl)-, Monohydrochloride

21. Nsc 60256

22. Chlorazanil Hydrochloride [mi]

23. Akos024332744

24. Cs-4566

25. Chlorazanil Hydrochloride [mart.]

26. Chlorazanil Hydrochloride [who-dd]

27. Q27272176

28. 1,5-triazine-2,4-diamine, N-(4-chlorophenyl)-, Monohydrochloride

29. N-(4-chloro-phenyl)-[1,3,5]triazine-2,4-diamine Hydrochloride

30. N-(4-chlorophenyl)-6-imino-1,6-dihydro-1,3,5-triazin-2-amine--hydrogen Chloride (1/1)

2.4 Create Date
2007-12-12
3 Chemical and Physical Properties
Molecular Weight 258.10 g/mol
Molecular Formula C9H9Cl2N5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass257.0235007 g/mol
Monoisotopic Mass257.0235007 g/mol
Topological Polar Surface Area76.7 Ų
Heavy Atom Count16
Formal Charge0
Complexity195
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty